Physician profile
Stephen C Anderson
NPI 1306867833
$5,685.25
in general payments reported to CMS, 2019-2025
30 companies · $927 in 2025
The $927 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,255 · 2020: $1,504 · 2021: $1,339 · 2022: $15.34 · 2023: $236 · 2024: $410 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,572.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,117.69 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,086.41 | 2019-2025 | Airsupra, Farxiga |
| Lilly USA, LLC | $648.64 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $459.17 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Merck Sharp & Dohme LLC | $456.18 | 2019-2025 | Gardasil 9, Capvaxive, M-M-R II |
| Janssen Pharmaceuticals, INC | $418.13 | 2019-2021 | |
| Novo Nordisk INC | $344.04 | 2019-2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.66 | 2019-2024 | Jardiance, Tradjenta |
| Teva Pharmaceuticals USA, INC. | $108.08 | 2019-2021 | |
| Exact Sciences Corporation | $101.87 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbott Laboratories | $86.83 | 2021-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| E.R. Squibb & Sons, L.L.C. | $72.84 | 2019-2024 | Eliquis |
| Abbvie INC. | $64.41 | 2021-2025 | |
| Alkermes, INC. | $61.41 | 2019-2025 | Vivitrol |
| Amgen INC. | $51.37 | 2025 | Repatha |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $44.85 | 2025 | Thinprep 2000 Processor, Aptima |
| Novartis Pharmaceuticals Corporation | $39.17 | 2019-2020 | |
| Amarin Pharma, INC. | $34.79 | 2020-2021 | |
| Krystal Biotech INC | $34.32 | 2025 | Vyjuvek |
| Kowa Pharmaceuticals America, INC. | $30.52 | 2025 | Zoryve |
| Astellas Pharma US INC | $29.31 | 2025 | Veozah |
| Viatris Specialty LLC | $26.74 | 2025 | Yupelri |
| Axsome Therapeutics, INC. | $26.60 | 2025 | Auvelity |
| Heartflow, INC. | $26.14 | 2023 | Ffrct |
| Alk-Abello, INC | $23.92 | 2025 | Neffy |
| Allergan, INC. | $23.22 | 2020 | |
| Argenx US, INC. | $19.72 | 2025 | Vyvgart, Vyvgart Hytrulo |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.63 | 2019 | |
| Seqirus USA INC | $15.35 | 2025 | Flucelvax, Fluad |
| Takeda Pharmaceuticals U.S.A., INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.